• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

Exploring the Potential of (5-Chloropyrazin-2-yl)(pyrrolidin-1-yl)methanone in Contemporary Research

The compound with CAS No. 1245215-68-2, commonly referred to as (5-Chloropyrazin-2-yl)(pyrrolidin-1-yl)methanone, has emerged as a significant molecule in the field of organic chemistry and drug discovery. This compound, characterized by its unique structure combining a pyrazine ring, a chloro substituent, and a pyrrolidine moiety, has garnered attention due to its potential applications in medicinal chemistry and materials science. Recent studies have highlighted its role in modulating biological pathways and its utility as a building block for more complex molecular architectures.

One of the key features of (5-Chloropyrazin-2-yl)(pyrrolidin-1-yl)methanone is its versatility in synthetic chemistry. Researchers have exploited its reactivity to develop novel synthetic routes for constructing bioactive molecules. For instance, the pyrazine ring serves as an electron-deficient aromatic system, making it amenable to various electrophilic substitutions. This property has been leveraged in the synthesis of heterocyclic compounds with potential pharmacological activities. Recent advancements in catalytic methods have further enhanced the efficiency of these transformations, enabling the production of enantiomerically enriched derivatives.

In terms of biological activity, (5-Chloropyrazin-2-yl)(pyrrolidin-1-yl)methanone has shown promise as a modulator of protein-protein interactions (PPIs). PPIs are critical for many cellular processes, and disrupting them has become a strategic approach in drug development. Studies conducted using this compound have demonstrated its ability to bind to specific protein targets, thereby inhibiting their interaction with other molecules. This finding opens new avenues for developing therapeutic agents targeting diseases such as cancer and neurodegenerative disorders.

The integration of computational chemistry techniques has further deepened our understanding of this compound's properties. Molecular docking studies have revealed that the chloro-substituted pyrazine ring plays a pivotal role in determining the compound's binding affinity to target proteins. Additionally, quantum mechanical calculations have provided insights into the electronic structure of the molecule, shedding light on its reactivity and stability under various conditions. These computational tools have not only accelerated drug discovery but also facilitated the design of more potent analogs.

Another area where (5-Chloropyrazin-2-yl)(pyrrolidin-1-yl)methanone has made an impact is in materials science. Its ability to form stable coordination complexes with transition metals has led to its use in designing new materials for catalysis and sensing applications. Recent research has focused on incorporating this compound into metalloporphyrins and metallophthalocyanines, which exhibit exceptional catalytic activity in organic transformations. Furthermore, its photochemical properties make it a candidate for applications in optoelectronic devices.

From a synthetic perspective, the preparation of (5-Chloropyrazin-2-yl)(pyrrolidin-1-y)l)methanone involves a multi-step process that typically begins with the synthesis of 5-chloropyrazine derivatives. The subsequent condensation reaction with pyrrolidine derivatives under controlled conditions yields the final product. Optimization of reaction conditions, such as temperature and solvent choice, has been crucial in achieving high yields and purity levels.

In conclusion, CAS No. 1245215

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)